HomeRX • CVE
add
Biosyent Inc
Previous close
$8.55
Day range
$8.45 - $8.53
Year range
$7.03 - $9.26
Market cap
99.27M CAD
Avg Volume
5.92K
P/E ratio
15.92
Dividend yield
2.13%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 8.27M | 10.88% |
Operating expense | 5.18M | 8.25% |
Net income | 1.45M | 20.95% |
Net profit margin | 17.54 | 9.08% |
Earnings per share | — | — |
EBITDA | 1.61M | 5.75% |
Effective tax rate | 21.78% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.19M | -8.74% |
Total assets | 41.53M | 2.58% |
Total liabilities | 6.77M | -4.96% |
Total equity | 34.76M | — |
Shares outstanding | 11.61M | — |
Price to book | 2.89 | — |
Return on assets | 9.22% | — |
Return on capital | 10.65% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.45M | 20.95% |
Cash from operations | 674.99K | -68.75% |
Cash from investing | -916.50K | 38.17% |
Cash from financing | -1.29M | -27.08% |
Net change in cash | -1.68M | -395.87% |
Free cash flow | -3.81M | -74.76% |
About
Founded
1947
Headquarters
Website